Apollo Hospitals Delivers Strong June 2025 Quarter with Robust Profit Growth.

Apollo Hospitals has reported a healthy performance in the June 2025 quarter, with double-digit growth across revenue, operating profit, and earnings. Sales increased 15% YoY, rising from ₹5,086 crore in June 2024 to ₹5,842 crore, driven by continued business expansion. EBIDT grew 26%, from ₹675 crore to ₹852 crore, reflecting improved operational efficiency. Net profit jumped 42% YoY, from ₹316 crore to ₹441 crore, while EPS also rose 42%, from ₹21.23 to ₹30.10, delivering higher shareholder returns. At the current price of ₹7,236, with a market cap of ₹1,04,050 crore and a PE ratio of 66.1, the stock trades at a rich valuation, indicating strong investor confidence in its growth trajectory. In short: Apollo Hospitals has delivered a solid quarter with strong profit growth and healthy revenue gains, backed by operational improvements. Premium valuations suggest the market expects this growth momentum to continue.